Skip to main content

SCYNEXIS ALERT: Bragar Eagel & Squire, P.C. is Investigating SCYNEXIS, Inc. on Behalf of Scynexis Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against SCYNEXIS, Inc. (“Scynexis” or the “Company”) (NASDAQ: SCYX) on behalf of Scynexis stockholders. Our investigation concerns whether Scynexis has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On September 25, 2023, Scynexis announced a recall of its anti-fungal therapy ibrexafungerp and placing a temporary hold on its clinical studies due to the risk of a potential contaminant. The Company stated that the decision to recall follows an investigation that found the production of a contaminant called a beta-lactam drug substance during ibrexafungerp's manufacturing process. The non-antibacterial compound can lead to hypersensitivity or allergic reactions in some individuals.

On this news, Scynexis's stock price fell $1.38 per share, or 41.69%, over the following two trading sessions, to close at $1.38 per share on September 26, 2023.

If you purchased or otherwise acquired Scynexis shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.